EMA/PE/0000241327 - paediatric investigation plan

palopegteriparatide

Key facts

• Invented name:
  Yorvipath
• Active substance:
  palopegteriparatide
• Therapeutic area:
  Endocrine disorders
• Decision number:
  EMA/PE/0000241327
• PIP number:
  EMA/PE/0000241327
• Pharmaceutical form(s):
  Solution for injection
• Condition(s) / indication(s):
  Treatment of hypoparathyroidism
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  16/05/2025
• Compliance check done:
  Ne

Decision

EMA/PE/0000241327 : EMA decision of 16 May 2025 on the acceptance of a modification of an agreed paediatric investigation plan for palopegteriparatide (Yorvipath)

Adopted Reference Number: EMADOC-1700519818-2115791